509094-02-4 Usage
Uses
Used in Pharmaceutical Synthesis:
(4-(cyclohexylamino)-3-nitrophenyl)methanol is used as a precursor in the pharmaceutical industry for the synthesis of various organic compounds and pharmaceuticals. Its unique structure allows it to be a key intermediate in the production of drugs with specific therapeutic targets.
Used in Organic Chemistry:
In the field of organic chemistry, (4-(cyclohexylamino)-3-nitrophenyl)methanol is utilized as a building block for the creation of complex organic molecules. Its functional groups enable it to participate in a variety of chemical reactions, facilitating the development of new chemical entities with potential applications in various industries.
Used in Biological Research:
(4-(cyclohexylamino)-3-nitrophenyl)methanol is employed in biological research as a compound of interest for its potential anti-inflammatory and anti-cancer properties. Researchers investigate its mechanisms of action and interactions with biological systems to explore its therapeutic potential and possible side effects.
Used in Environmental and Health Risk Assessment:
Due to its potential hazardous effects, (4-(cyclohexylamino)-3-nitrophenyl)methanol is also used in environmental and health risk assessment studies. These studies aim to understand the compound's impact on ecosystems and human health, guiding the development of safe handling protocols and regulations for its use in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 509094-02-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,9,0,9 and 4 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 509094-02:
(8*5)+(7*0)+(6*9)+(5*0)+(4*9)+(3*4)+(2*0)+(1*2)=144
144 % 10 = 4
So 509094-02-4 is a valid CAS Registry Number.
InChI:InChI=1/C13H18N2O3/c16-9-10-6-7-12(13(8-10)15(17)18)14-11-4-2-1-3-5-11/h6-8,11,14,16H,1-5,9H2
509094-02-4Relevant academic research and scientific papers
Indazole derivatives as modulators of interleukin-1 receptor-associated kinase
-
Page/Page column 20, (2011/07/06)
The present invention relates to modulators of IRAK kinases of formula (I) and provides compositions comprising such modulators, as well as methods therewith for treating IRAK-mediated or IRAK-associated conditions or diseases.
Benzimidazole derivatives
-
, (2008/06/13)
Compounds, pharmaceutical compositions and methods are provided that are useful in the treatment of inflammatory and immune-related conditions or disorders. In particular, the invention provides compounds which modulate the expression and/or function of proteins involved in inflammation, immune response regulation and cell proliferation. The subject compounds are 2-amino-imidazole derivatives.
